Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson (NYSE:JNJ) executive, as the company’s new chief internal medicine officer to boost the company's efforts in obesity drug ...

NEW BRUNSWICK, N.J., March 05, 2025--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 15th to review first-quarter results. Joaquin ...

Johnson & Johnson (NYSE:JNJ) is one of the biggest pharmaceutical companies in the world. Its heft has enabled the stock to endure despite a multi-billion dollar lawsuit that the firm will take ...

Johnson & Johnson (JNJ) announced last night its decision ... and streamline your search for investment opportunities with TipRanks’ Stock Screener. Published first on TheFly – the ultimate ...

Over the past year, market research and investor surveys have consistently indicated a strong preference for the new ticker symbol, reinforcing the Company’s commitment to its AI-centric approach. As ...

Several other equities analysts have also recently issued reports on the stock. Argus upgraded shares of Johnson & Johnson to a “strong-buy” rating in a research note on Friday, January 24th.

Investors in Johnson & Johnson (Symbol: JNJ) saw new options begin trading today, for the April 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the JNJ ...

We recently published a list of 14 Best Holding Company Stocks to Buy Right Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best ...

today announced that the ticker symbol for its Class A Common Stock will officially change from “FFIE” to “FFAI” on Monday, March 10. In addition, the ticker symbol for the Company’s ...

14 analysts have shared their evaluations of Johnson & Johnson JNJ during the recent ... sectors (typically once per quarter for each stock). Analysts usually derive their information from company ...